CVS Health Corporation CVS
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 2,253.30% | 7.92% | -44.47% | -61.68% | -90.65% |
| Total Depreciation and Amortization | -1.87% | -2.40% | -1.00% | 0.20% | 0.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -87.38% | 9,662.71% | 10,923.08% | 2,794.37% | 784.24% |
| Change in Net Operating Assets | 399.29% | 76.31% | -144.64% | -1,452.29% | 84.71% |
| Cash from Operations | 105.38% | 95.30% | 17.95% | 16.82% | 97.55% |
| Capital Expenditure | -11.54% | -8.39% | -4.22% | -1.83% | 3.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 94.99% | -90.06% | -367.78% | -358.95% | -114.15% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -275.97% | -28.71% | 22.18% | 45.05% | 77.51% |
| Cash from Investing | -70.66% | -20.48% | 4.74% | 22.88% | 46.80% |
| Total Debt Issued | -100.00% | -47.39% | -45.73% | -59.63% | 43.12% |
| Total Debt Repaid | 29.46% | -56.15% | 10.90% | -20.43% | -253.04% |
| Issuance of Common Stock | 29.97% | 29.63% | 16.89% | 9.14% | -13.26% |
| Repurchase of Common Stock | -26.17% | -40.60% | 3.11% | 95.07% | 95.36% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -0.97% | -1.04% | -0.92% | -0.71% | -2.29% |
| Other Financing Activities | -243.90% | -254.55% | -166.67% | -100.00% | 415.38% |
| Cash from Financing | -245.94% | -214.01% | -119.91% | -335.24% | 2.40% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17.36% | 38.62% | -341.42% | -147.91% | 135.48% |